These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25993660)

  • 1. Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer.
    Ansong E; Ying Q; Ekoue DN; Deaton R; Hall AR; Kajdacsy-Balla A; Yang W; Gann PH; Diamond AM
    PLoS One; 2015; 10(5):e0127295. PubMed ID: 25993660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium-binding protein 1 alters energy metabolism in prostate cancer cells.
    Elhodaky M; Hong LK; Kadkol S; Diamond AM
    Prostate; 2020 Sep; 80(12):962-976. PubMed ID: 32511787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenium-Binding Protein 1 in Human Health and Disease.
    Elhodaky M; Diamond AM
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue.
    Jerome-Morais A; Wright ME; Liu R; Yang W; Jackson MI; Combs GF; Diamond AM
    Prostate; 2012 Jun; 72(9):1006-12. PubMed ID: 22072582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma.
    Tan X; Liao L; Wan YP; Li MX; Chen SH; Mo WJ; Zhao QL; Huang LF; Zeng GQ
    World J Surg Oncol; 2016 Mar; 14():70. PubMed ID: 26956891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarrays.
    Ananthanarayanan V; Deaton RJ; Amatya A; Macias V; Luther E; Kajdacsy-Balla A; Gann PH
    Hum Pathol; 2011 Jun; 42(6):873-81. PubMed ID: 21292307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD147 expression predicts biochemical recurrence after prostatectomy independent of histologic and pathologic features.
    Bauman TM; Ewald JA; Huang W; Ricke WA
    BMC Cancer; 2015 Jul; 15():549. PubMed ID: 26209327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Critical Role for Cysteine 57 in the Biological Functions of Selenium Binding Protein-1.
    Ying Q; Ansong E; Diamond AM; Yang W
    Int J Mol Sci; 2015 Nov; 16(11):27599-608. PubMed ID: 26593911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1α to promote hepatocellular carcinoma invasiveness.
    Huang C; Ding G; Gu C; Zhou J; Kuang M; Ji Y; He Y; Kondo T; Fan J
    Clin Cancer Res; 2012 Jun; 18(11):3042-53. PubMed ID: 22512980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of selenium-binding protein 1 sensitizes cancer cells to selenite via elevating extracellular glutathione: a novel mechanism of cancer-specific cytotoxicity of selenite.
    Wang Y; Fang W; Huang Y; Hu F; Ying Q; Yang W; Xiong B
    Free Radic Biol Med; 2015 Feb; 79():186-96. PubMed ID: 25445402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy.
    Hamid AA; Gray KP; Huang Y; Bowden M; Pomerantz M; Loda M; Sweeney CJ
    Eur Urol Oncol; 2019 Sep; 2(5):475-482. PubMed ID: 31411988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.
    Lee G; Veltri RW; Zhu G; Ali S; Epstein JI; Madabhushi A
    Eur Urol Focus; 2017 Oct; 3(4-5):457-466. PubMed ID: 28753763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
    Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
    Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium Selenite Inhibits Proliferation of Gastric Cancer Cells by Inducing SBP1 Expression.
    Gong J; Li L
    Tohoku J Exp Med; 2016 Aug; 239(4):279-85. PubMed ID: 27477809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence.
    Tsourlakis MC; Schoop M; Plass C; Huland H; Graefen M; Steuber T; Schlomm T; Simon R; Sauter G; Sirma H; Minner S
    Hum Pathol; 2013 Sep; 44(9):1789-96. PubMed ID: 23642739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.
    Bauman TM; Becka AJ; Sehgal PD; Huang W; Ricke WA
    Hum Pathol; 2015 Nov; 46(11):1744-51. PubMed ID: 26344417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seminal plasma proteins in prostatic carcinoma: increased nuclear semenogelin I expression is a predictor of biochemical recurrence after radical prostatectomy.
    Izumi K; Li Y; Zheng Y; Gordetsky J; Yao JL; Miyamoto H
    Hum Pathol; 2012 Nov; 43(11):1991-2000. PubMed ID: 22617231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer.
    Gerke T; Beltran H; Wang X; Lee GM; Sboner A; Karnes RJ; Klein EA; Davicioni E; Yousefi K; Ross AE; Börnigen D; Huttenhower C; Mucci LA; Trock BJ; Sweeney CJ
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):584-590. PubMed ID: 30420441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.